Radiology Doctors in Hot Springs, AR Accepting Medicare

5 Radiology doctors found. Showing 1 - 5

James R Mccarley, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3633 Central Avenue, Suite D, Hot Springs, AR 71913 Phone: 501-623-6693    Fax: 501-623-9403

Kremer B Nicholas, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3633 Central Avenue, Suite D, Hot Springs, AR 71913 Phone: 501-623-6693    Fax: 501-623-9403

Lonnie Benton Wright, M.D. Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 310 Crestview Dr, Hot Springs, AR 71913 Phone: 501-520-7782

Edward Herbert Abraham, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 1455 Higdon Ferry Rd Ste C, Hot Springs, AR 71913 Phone: 501-622-2100

Claude E Fendley, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1661 Airport Rd, Suite D, Hot Springs, AR 71913 Phone: 501-760-1513    Fax: 501-767-8014

News Archive

Access to anesthesia care not increased when states ‘opt-out' of Medicare rule, study finds

Patient access to anesthesia care for seven common surgical procedures is not increased when states "opt-out" of the Medicare rule that requires anesthesia to be administered with physician supervision, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

Symphogen announced today that Phase 2 data will be presented from an open-label, multi-center clinical trial evaluating the safety and tolerability of rozrolimupab in adult, RhD positive, non-splenectomized patients with Immune thrombocytopenia (ITP) at the 16th Congress of the European Hematology Association meeting in London, UK on June 10 from 5:45 to 7:00 PM.

Four-drug regimen shows first-line efficacy in advanced NSCLC

A four-drug combination of cetuximab, bevacizumab, carboplatin, and paclitaxel is effective and has acceptable safety as a first-line treatment for advanced non-small-cell lung cancer, US researchers report.

Bio-Path Holdings to develop liposome tumor targeting technology

Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today the Company has executed an exclusive license with The University of Texas M. D. Anderson Cancer Center to develop liposome tumor targeting technology. Bio-Path is currently developing a neutral-lipid based liposome delivery technology for nucleic acid cancer drugs (including antisense and siRNA molecules).

AbleNet to showcase assistive technology products at Heartland Home for Independent Living

AbleNet, Inc. is showcasing its newest and most popular access, environmental controls and communications products at the Heartland Home for Independent Living. The model home is being constructed as an all-accessible home to give conference attendees first-hand experience with the many innovative design features and the leading accessibility products that enhance independent and functional living for people with disabilities.

Read more Medical News

› Verified 3 days ago